• Gilead-partnered Teneobio and its next-gen cancer work snapped up by Amgen for $2.5B

    1 month ago - By Fierce Biotech

    Gilead-partnered Teneobio and its next-gen cancer work snapped up by Amgen for $2.5B badams
    Wed, 07/28/2021 - 04:30
    Read more ...

     

  • GSK culls phase 2 RSV vaccine in kids, as feladilimab flops again in lung cancer

    1 month ago - By Fierce Biotech

    GSK culls phase 2 RSV vaccine in kids, as feladilimab flops again in lung cancer ntaylor
    Wed, 07/28/2021 - 08:54
    Read more ...